Renishaw plc with ticker (LON:RSW) now has a potential downside of -3.8% according to Barclays.
Barclays set a target price of 4,200 GBX for the company, which when compared to the Renishaw plc share price of 4,358 GBX at opening today (24/02/2022) indicates a potential downside of -3.8%. Trading has ranged between 4,226 (52 week low) and 7,025 (52 week high) with an average of 84,241 shares exchanging hands daily. The market capitalisation at the time of writing is £3,141,552,954.
Renishaw plc is a engineering and scientific technology company. The Company’s segments include Manufacturing technologies and Analytical instruments and medical devices. The Company’s Manufacturing technologies segment manufactures metal part on machine tools and additive manufacturing systems (AM). It also provides easy-to-use solutions with data analytics. The Company’s Analytical instruments and medical devices segment offers a range of applications, including advanced materials analysis, brain surgery, facial reconstructive surgery and dentistry. Its robots and drug delivery devices help deliver precision for life-enhancing therapies for neurological conditions. It also supplies configured metal additive manufacturing systems for medical and dental applications. The Company offers its services to the markets, such as aerospace, agriculture, automotive, construction, consumer electronics, healthcare, power generation and resource exploration.
Renishaw plc -3.8% potential downside indicated by Barclays
[shareaholic app="share_buttons" id_name="post_below_content"]
- Written by: Charlotte Edwards
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Renishaw plc (LON:RSW) has released a trading update for the nine months ended 31 March 2024, showing solid performance and signs of semiconductor equipment recovery.
Renishaw plc has released its interim report for the six months ended December 31, 2023. Revenue decreased by 5% to £330.5m, with various factors impacting the results.